Chesapeake Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Sell
3,846
-103
-3% -$41.8K 0.52% 52
2025
Q1
$1.97M Sell
3,949
-137
-3% -$68.2K 0.7% 46
2024
Q4
$2.13M Sell
4,086
-4
-0.1% -$2.08K 0.73% 45
2024
Q3
$2.53M Sell
4,090
-96
-2% -$59.4K 0.86% 40
2024
Q2
$2.31M Sell
4,186
-63
-1% -$34.8K 0.84% 41
2024
Q1
$2.47M Sell
4,249
-178
-4% -$103K 0.9% 37
2023
Q4
$2.35M Sell
4,427
-71
-2% -$37.7K 0.91% 34
2023
Q3
$2.28M Sell
4,498
-75
-2% -$38K 0.95% 32
2023
Q2
$2.39M Sell
4,573
-103
-2% -$53.7K 0.94% 32
2023
Q1
$2.7M Buy
4,676
+7
+0.1% +$4.04K 1.12% 24
2022
Q4
$2.57M Sell
4,669
-145
-3% -$79.9K 1.13% 26
2022
Q3
$2.44M Sell
4,814
-143
-3% -$72.5K 1.11% 26
2022
Q2
$2.69M Sell
4,957
-225
-4% -$122K 1.15% 21
2022
Q1
$3.06M Sell
5,182
-138
-3% -$81.5K 1.11% 23
2021
Q4
$3.55M Sell
5,320
-148
-3% -$98.8K 1.19% 21
2021
Q3
$3.12M Sell
5,468
-600
-10% -$343K 1.12% 21
2021
Q2
$3.06M Sell
6,068
-492
-8% -$248K 0.99% 22
2021
Q1
$2.99M Sell
6,560
-802
-11% -$366K 1% 19
2020
Q4
$3.43M Sell
7,362
-120
-2% -$55.9K 1.17% 18
2020
Q3
$3.3M Buy
7,482
+35
+0.5% +$15.5K 1.23% 14
2020
Q2
$2.7M Buy
7,447
+116
+2% +$42K 1.07% 19
2020
Q1
$2.08M Buy
7,331
+93
+1% +$26.4K 0.96% 21
2019
Q4
$2.35M Buy
7,238
+295
+4% +$95.8K 0.91% 22
2019
Q3
$2.02M Buy
6,943
+260
+4% +$75.8K 0.82% 26
2019
Q2
$1.96M Buy
6,683
+1,013
+18% +$298K 0.82% 26
2019
Q1
$1.55M Buy
5,670
+442
+8% +$121K 0.68% 37
2018
Q4
$1.17M Buy
5,228
+626
+14% +$140K 0.58% 46
2018
Q3
$1.12M Buy
4,602
+209
+5% +$51K 0.5% 53
2018
Q2
$910K Buy
4,393
+249
+6% +$51.6K 0.42% 64
2018
Q1
$856K Buy
+4,144
New +$856K 0.4% 71